4) mouton was doing fine by himself correcting you mis-statements. And your debate with mouton was fixing the Dew errors.
Well that contradiction will have some people scratching their heads!
You can give examples - but I will give just one - here's mouton quoting Dew - http://investorshub.advfn.com/boards/read_msg.aspx?message_id=76905247 <<The FDA can approve NVS/MNTA’s Copaxone ANDA irrespective of the patent litigation.>> - and then agreeing 100% with him: What you say makes sense, else how would generics be launched at-risk.